{"name":"Institut d'Investigació Biomèdica de Bellvitge","slug":"institut-d-investigaci-biom-dica-de-bellvitge","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1MUHpLYW1UdVF5Q0ZrZnJtU2RBZWJwYl84WVRNSHNlMVBYenA5UDVQN0huWWNrSF9VN2IxR2RRUXVYek9WLU16RXlGUDViQlJJck45RXM4TFFXUXZSM3c4?oc=5","date":"2025-05-14","type":"pipeline","source":"Nature","summary":"Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recomm","headline":"Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1zWTA3eUFNVU5oRElWYTRjYUNua0FnRU5LY2JIU3pzUVgtZlZERng5VGVSZC0wd2R4ejlwR21Za0xPaGQtMUt4RUExSENJeWxWYXJBd1FIb3d0MFowYW9v?oc=5","date":"2023-10-02","type":"trial","source":"Nature","summary":"Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial - Nature","headline":"Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a ran","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2022-06-26","type":"pipeline","source":"EL PAÍS English","summary":"Aspirin for cancer and thalidomide for leprosy: new life for old drugs - EL PAÍS English","headline":"Aspirin for cancer and thalidomide for leprosy: new life for old drugs - EL PAÍS English","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBUVW1OQkxyODRLY1VLWDZabTlzYmNneUZRU1BjR01ndWpfSHpMSFZwY2I2S2o1cWJ1WHhCVW1CVVJFTEhvSmc5U2lnWUNMMWxfd1ltbEl3NDlBUnZLWG1N?oc=5","date":"2021-01-22","type":"trial","source":"Nature","summary":"Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML - Nature","headline":"Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}